CARIS LIFE SCIENCES INC (CAI)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for CAI
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CAI | President and Chief Operating Officer of Glaukos Corporation | 50 | ["Chief Financial Officer and Senior Vice President, Corporate Development at Glaukos Corporation","Managing Director in the Healthcare Investment Banking group at JPMorgan Chase & Co.","Experience in mergers and acquisitions, public equity offerings, bank lending, bond offerings","Auditor at PricewaterhouseCoopers LLP","Bachelor of Science in accounting from the Kelly School of Business at Indiana University"] | ["Member","Audit","Compensation"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| GKOS | President and Chief Operating Officer | ["B.S. in accounting from the Kelly School of Business at Indiana University","served as Chief Financial Officer and Senior Vice President, Corporate Development","experience in accounting, financing, business development, investor relations, regulatory, internal audit","Managing Director in Healthcare Investment Banking at JPMorgan Chase & Co.","experience in mergers and acquisitions, public equity offerings, bank lending, bond offerings","started career at PricewaterhouseCoopers LLP"] | ["audit","compensation"] | 2026 |
Biography sourced from the proxy statement filing.
Joseph E. Gilliam has served as a member of our board of directors since April 2021. Mr. Gilliam is currently the President and Chief Operating Officer at Glaukos Corporation, an ophthalmic pharmaceutical and medical device company, a position he has held since April 2022. From May 2017 to April 2022, Mr. Gilliam was Chief Financial Officer and Senior Vice President, Corporate Development at Glaukos Corporation. Prior to Glaukos Corporation, Mr. Gilliam served as a Managing Director in the Healthcare Investment Banking group at JPMorgan Chase & Co., from 2013 to May 2017, where he led the initial public offering for Glaukos Corporation. From 2000 to 2013, Mr. Gilliam held positions of increasing responsibility at JP Morgan Chase and its predecessor organizations The Beacon Group and Chase Manhattan, with experience spanning mergers and acquisitions, primary and secondary public equity offerings, bank lending, bond offerings and other transactions. Mr. Gilliam started his career at PricewaterhouseCoopers LLP as an Auditor. Mr. Gilliam holds a Bachelor of Science in accounting from the Kelly School of Business at Indiana University. We believe Mr. Gilliam s extensive experience in the investment and healthcare industries and knowledge of healthcare companies make him well-qualified to serve as a member of our Board of Directors.